Recap: HilleVax Q4 Earnings
Portfolio Pulse from Benzinga Insights
HilleVax (NASDAQ:HLVX) reported Q4 earnings, beating estimates with an EPS of $-0.78 against an expected $-0.83, a 6.0% beat. However, revenue remained unchanged from the previous year. Following a similar earnings beat last quarter, HLVX's share price increased by 6.0% the next day.
March 20, 2024 | 9:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HilleVax reported a Q4 EPS of $-0.78, surpassing estimates by 6.0%, with unchanged revenue from the previous year. Last quarter's beat led to a 6.0% share price increase the following day.
HilleVax's Q4 earnings beat is likely to positively impact its stock price in the short term, similar to the aftermath of its last earnings beat. The consistent performance in beating EPS estimates, coupled with the historical reaction of a 6.0% share price increase following the last earnings beat, suggests a positive outlook for HLVX's stock. However, the unchanged revenue could temper some of the enthusiasm, hence the importance is not at the maximum.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100